NeuroScientific Biopharmaceuticals Limited (ASX:NSB)

ASX:NSB Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 8, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	33	29	6	11	26	48
Market Cap Growth	557.11%	400.23%	-49.60%	-55.56%	-46.27%	222.72%
Enterprise Value	27	24	2	8	16	43
Last Close Price	0.10	0.09	0.04	0.08	0.18	0.34
PE Ratio	-	-	17.84	-	-	-
PS Ratio	104.61	-	2.62	2.32	-	50.13
PB Ratio	2.02	1.72	1.08	2.44	4.68	3.29
P/TBV Ratio	5.22	3.99	1.17	2.60	4.97	3.38
P/FCF Ratio	-	-	136.31	-	-	-
P/OCF Ratio	-	-	130.72	-	-	-
EV/Sales Ratio	84.62	-	1.11	1.65	-	44.93
EV/EBITDA Ratio	-	-	9.93	-	-	-
EV/EBIT Ratio	-	-	15.76	-	-	-
EV/FCF Ratio	-	-	57.68	-	-	-
Net Debt / Equity Ratio	-0.39	-0.43	-0.93	-1.05	-1.31	-0.97
Net Debt / EBITDA Ratio	2.36	3.79	-20.09	4.41	0.69	4.42
Net Debt / FCF Ratio	4.58	7.72	-116.75	2.13	1.04	5.38
Asset Turnover	0.03	-	0.41	0.76	-	0.10
Quick Ratio	31.14	49.35	58.46	8.30	3.31	63.61
Current Ratio	31.62	49.56	58.87	8.39	3.34	64.58
Return on Equity (ROE)	-29.65%	-16.65%	6.46%	-20.93%	-103.71%	-34.82%
Return on Assets (ROA)	-19.42%	-11.21%	1.81%	-11.24%	-58.19%	-21.98%
Return on Capital Employed (ROCE)	-20.50%	-11.90%	2.90%	-25.00%	-190.30%	-22.40%
Earnings Yield	-9.55%	-6.38%	5.61%	-9.31%	-40.41%	-6.61%
FCF Yield	-	-3.25%	0.73%	-20.08%	-26.90%	-5.47%
Buyback Yield / Dilution	-64.61%	-1.49%	-0.72%	-	-	-83.04%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.